The use of error-corrected sequencing (ECS) with a detection limit as low as 0.03% has revealed that CHIP mutations with a VAF above 1% are relevant for predicting the future development of acute myeloid leukemia (AML), while clones below this threshold show a weaker association [102]. Here, STUB1 is linked to acute myeloid leukemia.